Non-Arteritic Anterior Ischemic Optic Neuropathy
6 clinical trials · Condition
◉ Watch Non-Arteritic Anterior Ischemic Optic Neuropathy
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) (NCT07453888) | Dompé Farmaceutici S.p.A | 2026-07-01 |
| Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) (NCT03046693) | Valen Chia | 2017-01-16 |
| Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (NCT02341560) | Quark Pharmaceuticals | 2016-02-24 |
| Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients (NCT01064505) | Quark Pharmaceuticals | 2010-02-01 |
| Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy (NCT00813059) | Mount Sinai Hospital, Canada | 2009-02-01 |
| Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy (NCT00140491) | Emory University | 2005-08-01 |
Track Non-Arteritic Anterior Ischemic Optic Neuropathy automatically
Every clearance here is in the API, with alerts when new ones post.